Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
Each year, to mark International Women in Engineering Day, we like to find out what motivated women in our network to pursue an education or career in science, technology, engineering and maths. In this special episode of the IP Podcast, Sarah Richmond (Senior Associate) interviewed Jessica Gagen, Aerospace Engineering Graduate, model and the reigning Miss England, about her journey to studying engineering and the importance of the female role model.
Alexandra Nott, Associate in the Dehns Trade Marks Group, discusses the Framework Cooperation Agreement signed by the IOC and the WIPO to promote the importance of IP rights for the international sports community.
Daniel Sanz Sharley, Technical Assistant in the Dehns Chemical Group, discusses the use of videoconference (ViCo) in oral proceedings held before the Boards of Appeal.
The UPC: the 5 Ws (and an H): Mark Bell, Partner at Dehns provides a thorough breakdown of the UPC.
After many years of planning, numerous stop-starts and a huge amount of hard work, it’s finally here: the Unified Patents Court (UPC), a game-changer in European patent law, is now open for business.
Nikolle Medford, Trade Mark Assistant at Dehns discusses some high-profile trade mark disputes and how they played out in the public eye.
Plausibility after Warner-Lambert and G2/21: A case analysis of Sandoz and Teva v Bristol Myers Squibb – Court of Appeal.
Tesco Shown a Yellow (Club) Card: Daniel Wheatley, Trade Mark Assistant at Dehns provides a case analysis of Lidl Great Britain Ltd & Anor v Tesco Stores Ltd & Anor [2023] EWHC 873 (Ch).
Future royalty term considerations at early stage R&D licences: In this article, David Pountney, Senior Associate, Litigation at Dehns provides a case analysis of AstraZeneca UK Ltd v Tesaro Inc.
Join us in celebrating the work of trailblazing women around the world and in raising awareness about why it is so important to encourage more women to participate in the IP system, to protect their valuable IP and commercialise their ideas.
To celebrate our own “Women in IP” we’re taking this opportunity to introduce Hanna Dzieglewska – Head of Dehns Biotechnology team.
Subscribe here for updates on IP news, events and webinars.
|